Evidence map›Paper›PMID 35508575›Full record

ArticleScientific reports2022

In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.

Alessandra Romano, Nunziatina Laura Parrinello, Martina Barchitta, Rosy Manuele, Fabrizio Puglisi, Andrea Maugeri, Alessandro Barbato, Anna Maria Triolo, Cesarina Giallongo, Daniele Tibullo and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Current neuropharmacology · 2025
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Alessandra Romano *Division of Hematology, Azienda Policlinico-Rodolico San Marco, Catania, Italy. alessandra.romano@unict.it.
Nunziatina Laura Parrinello *Division of Hematology, Azienda Policlinico-Rodolico San Marco, Catania, Italy. lauraparrinello@tiscali.it.
Martina BarchittaDepartment of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123, Catania, Italy.
Rosy ManueleU.O.C. di Malattie Infettive, Azienda Policlinico-Rodolico San Marco, Catania, Italy.
Fabrizio PuglisiDivision of Hematology, Azienda Policlinico-Rodolico San Marco, Catania, Italy.
Andrea MaugeriDepartment of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123, Catania, Italy.
Alessandro BarbatoDivision of Hematology, Azienda Policlinico-Rodolico San Marco, Catania, Italy.
Anna Maria TrioloDivision of Hematology, Azienda Policlinico-Rodolico San Marco, Catania, Italy.
Cesarina GiallongoDepartment of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123, Catania, Italy.
Daniele TibulloDipartimento di Scienze Biomediche e Biotecnologiche, University of Catania, Catania, Italy.
Lucia La FerlaU.O.C. di Malattie Infettive, Azienda Cannizzaro, Catania, Italy.
Ciro BottaDivision of Hematology, Università degli Studi di Palermo, Palermo, Italy.
Sergio SiragusaDivision of Hematology, Università degli Studi di Palermo, Palermo, Italy.
Carmelo IacobelloU.O.C. di Malattie Infettive, Azienda Cannizzaro, Catania, Italy.
Arturo MontineriU.O.C. di Malattie Infettive, Azienda Policlinico-Rodolico San Marco, Catania, Italy.
Giovanni Li VoltiDipartimento di Scienze Biomediche e Biotecnologiche, University of Catania, Catania, Italy.
Antonella AgodiDepartment of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, 95123, Catania, Italy.
Giuseppe Alberto Palumbo *Division of Hematology, Azienda Policlinico-Rodolico San Marco, Catania, Italy.
Francesco Di Raimondo *Division of Hematology, Azienda Policlinico-Rodolico San Marco, Catania, Italy.
Policlinico Universitario di Catania · ITUniversity of Catania · ITOspedale Cannizzaro · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since neutrophil extracellular traps formation (NET-osis) can be assessed indirectly by treating healthy neutrophils with blood-derived fluids from patients and then measuring the NETs response, we designed a pilot study to convey high-dimensional cytometry of peripheral blood immune cells and cytokines, combined with clinical features, to understand if NET-osis assessment could be included in the immune risk profiling to early prediction of clinical patterns, disease severity, and viral clearance at 28 days in COVID-19 patients. Immune cells composition of peripheral blood, cytokines concentration and in-vitro NETosis were detected in peripheral blood of 41 consecutive COVID-19 inpatients, including 21 mild breakthrough infections compared to 20 healthy donors, matched for sex and age. Major immune dysregulation in peripheral blood in not-vaccinated COVID-19 patients compared to healthy subjects included: a significant reduction of percentage of unswitched memory B-cells and transitional B-cells; loss of naïve CD3

Indexed as

COVID-19 Drug TreatmentBreakthrough InfectionsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCOVID-19COVID-19 VaccinesCytokinesHumansInterleukin-6Leukocyte Common AntigensPilot ProjectsSARS-CoV-2COVID-19 VaccinesCytokinesInterleukin-6Leukocyte Common Antigens

Identifiers

PMID35508575
PMCPMC9065667
OpenAlexW4225419687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.